New Product Briefs
This article was originally published in The Gray Sheet
Product news from Cyberonics, TransEnterix Dexcom, Boston Scientific, St. Jude, Medtronic and Roche.
You may also be interested in...
The US neurostimulation technology market will grow nearly 46% over the next five years, according to a new report from Medtech Insight.
The focus of the diabetes market is firmly on the development of an artificial pancreas, now within two or three years from becoming commercialized, and progress is going so well that several companies are in line to release a product. Meanwhile, digital health is increasingly playing a major role in diabetes care, and device manufacturers are investing in connectivity solutions to satisfy patient and consumer needs.
The excitement about digital health solutions has reached new heights as the market moves toward changes where those solutions are not only wanted, but in many cases needed to help battle costs and improve patient outcomes. The interest in digital health is part of a larger trend that is seeing patients take on more and more responsibility for their own health amid changing perceptions of what is considered a medical device.